The trace amine-associated receptor 1 modulates methamphetamine's neurochemical and behavioral effects

Frontiers in Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  Cotter, Rachel ^a   Pei, Yue ^a,b   Mus, Liudmila ^c   Harmeier, Anja ^d   Gainetdinov, Raul R ^c,e,f   Hoener, Marius C ^d   Canales, Juan J ^b  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

^f ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

Author keywords

Methamphetamine; Microdialysis; Self administration; Sensitization; Synaptosomes; Trace amine associated receptor

Indexed keywords

DOPAMINE; METHAMPHETAMINE; PARTIAL AGONIST; PSYCHOSTIMULANT AGENT; RECEPTOR; RO 5203648; SUCROSE; TRACE AMINE ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; BIOACCUMULATION; BRAIN SYNAPTOSOME; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; HYPERACTIVITY; IN VIVO STUDY; LOCOMOTION; LONG TERM EXPOSURE; NERVE STIMULATION; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PHYSIOLOGICAL PROCESS; RAT; SENSITIZATION; TIME TO TREATMENT;

EID: 84949117206     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00039     Document Type: Article

References (35)

1. Achat-Mendes, C., Lynch, L. J., Sullivan, K. A., Vallender, E. J., and Miller, G. M. (2012). Augmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1. Pharmacol. Biochem. Behav. 101, 201-207. doi: 10.1016/j.pbb.2011.10.025
2. Berry, M. D. (2004). Mammalian central nervous ssystem trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J. Neurochem. 90, 257-271. doi: 10.1111/j.1471-4159.2004.02501.x
3. Borowsky, B., Adham, N., Jones, K. A., Raddatz, R., Artymyshyn, R., Ogozalek, K. L., et al. (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 8966-8971. doi: 10.1073/pnas.151105198
4. Bradaia, A., Trube, G., Stalder, H., Norcross, R. D., Ozmen, L., Wettstein, J. G., et al. (2009). The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc. Natl. Acad. Sci. U.S.A. 106, 20081-20086. doi: 10.1073/pnas.0906522106
5. Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., et al. (2001). Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 60, 1181-1188. doi: 10.1124/mol.60.6.1181
6. Elliott, J. M., and Beveridge, T. J. (2005). Psychostimulants and monoamine transporters: upsetting the balance. Curr. Opin. Pharmacol. 5, 94-100. doi: 10.1016/j.coph.2004.09.005
7. Espinoza, S., Salahpour, A., Masri, B., Sotnikova, T. D., Messa, M., Barak, L. S., et al. (2011). Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol. Pharmacol. 80, 416-425. doi: 10.1124/mol.111.073304
8. Fleckenstein, A. E., Volz, T. J., and Hanson, G. R. (2009). Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications. Neuropharmacology 56(Suppl. 1), 133-138. doi: 10.1016/j.neuropharm.2008.07.002
9. Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., and Hanson, G. R. (2007). New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681-698. doi: 10.1146/annurev.pharmtox.47.120505.105140
10. Gilbert, D., and Cooper, S. J. (1983). beta-Phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats. Eur. J. Pharmacol. 95, 311-314. doi: 10.1016/0014-2999(83)90653-2
11. Goodwin, J. S., Larson, G. A., Swant, J., Sen, N., Javitch, J. A., Zahniser, N. R., et al. (2009). Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. J. Biol. Chem. 284, 2978-2989. doi: 10.1074/jbc. M805298200
12. Jing, L., Zhang, Y., and Li, J. X. (2014). Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in rats. Int. J. Neuropsychopharm. doi: 10.1093/ijnp/pyu060. [Epub ahead of print].
13. Leo, D., Mus, L., Espinoza, S., Hoener, M. C., Sotnikova, T. D., and Gainetdinov, R. R. (2014). Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology 81, 283-291. doi: 10.1016/j.neuropharm.2014.02.007
14. Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaia, A., Ozmen, L., Bluethmann, H., et al. (2008). Trace amine-associated receptor 1 modulates dopaminergic activity. J. Pharmacol. Exp. Ther. 324, 948-956. doi: 10.1124/jpet.107.132647
15. McGinty, J. F., Shi, X. D., Schwendt, M., Saylor, A., and Toda, S. (2008). Regulation of psychostimulant-induced signaling and gene expression in the striatum. J. Neurochem. 104, 1440-1449. doi: 10.1111/j.1471-4159.2008.05240.x
16. Nakagawa, T., Suzuki, Y., Nagayasu, K., Kitaichi, M., Shirakawa, H., and Kaneko, S. (2011). Repeated exposure to methamphetamine, cocaine or morphine induces augmentation of dopamine release in rat mesocorticolimbic slice co-cultures. PLoS ONE 6:e24865. doi: 10.1371/journal.pone.0024865
17. Pei, Y., Lee, J., Leo, D., Gainetdinov, R. R., Hoener, M. C., and Canales, J. J. (2014). Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seeking. Neuropsychopharmacology 39, 2299-2308. doi: 10.1038/npp.2014.88
18. Reese, E. A., Bunzow, J. R., Arttamangkul, S., Sonders, M. S., and Grandy, D. K. (2007). Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine. J. Pharmacol. Exp. Ther. 321, 178-186. doi: 10.1124/jpet.106.115402
19. Revel, F. G., Meyer, C. A., Bradaia, A., Jeanneau, K., Calcagno, E., Andre, C. B., et al. (2012a). Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine. Neuropsychopharmacology 37, 2580-2592. doi: 10.1038/npp.2012.109
20. Revel, F. G., Moreau, J. L., Gainetdinov, R. R., Bradaia, A., Sotnikova, T. D., Mory, R., et al. (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc. Natl. Acad. Sci. U.S.A. 108, 8485-8490. doi: 10.1073/pnas.1103029108
21. Revel, F. G., Moreau, J. L., Gainetdinov, R. R., Ferragud, A., Velazquez-Sanchez, C., Sotnikova, T. D., et al. (2012b). Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol. Psychiatry 72, 934-942. doi: 10.1016/j.biopsych.2012.05.014
22. Shannon, H. E., and Thompson, W. A. (1984). Behavior maintained under fixed-interval and second-order schedules by intravenous injections of endogenous noncatecholic phenylethylamines in dogs. J. Pharmacol. Exp. Ther. 228, 691-695.
23. Shuto, T., Kuroiwa, M., Hamamura, M., Yabuuchi, K., Shimazoe, T., Watanabe, S., et al. (2006). Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist. Neuropharmacology 50, 991-997. doi: 10.1016/j.neuropharm.2006.01.009
24. Sulzer, D., Sonders, M. S., Poulsen, N. W., and Galli, A. (2005). Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406-433. doi: 10.1016/j.pneurobio.2005.04.003
25. Thorn, D. A., Jing, L., Qiu, Y., Gancarz-Kausch, A. M., Galuska, C. M., Dietz, D. M., et al. (2014). Effects of the Trace Amine-Associated Receptor 1 Agonist RO5263397 on Abuse-Related Effects of Cocaine in Rats. Neuropsychopharmacology 39, 2309-2316. doi: 10.1038/npp.2014.91
26. Vanderschuren, L. J., and Kalivas, P. W. (2000). Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 151, 99-120. doi: 10.1007/s002130000493
27. Velazquez-Sanchez, C., Ferragud, A., Ramos-Miguel, A., Garcia-Sevilla, J. A., and Canales, J. J. (2013). Substituting a long-acting dopamine uptake inhibitor for cocaine prevents relapse to cocaine seeking. Addict. Biol. 18, 633-643. doi: 10.1111/j.1369-1600.2012.00458.x
28. Velazquez-Sanchez, C., Ferragud, A., Renau-Piqueras, J., and Canales, J. J. (2011). Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction. Int. J. Neuropsychopharmacol. 14, 655-665. doi: 10.1017/S1461145710000969
29. Wolf, M. E. (1998). The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720. doi: 10.1016/S0301-0082(97)00090-7
30. Wolinsky, T. D., Swanson, C. J., Smith, K. E., Zhong, H., Borowsky, B., Seeman, P., et al. (2007). The TRACE Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia. Genes Brain Behav. 6, 628-639. doi: 10.1111/j.1601-183X.2006.00292.x
31. Xie, Z., and Miller, G. M. (2007). Trace amine-associated receptor 1 is a modulator of the dopamine transporter. J. Pharmacol. Exp. Ther. 321, 128-136. doi: 10.1124/jpet.106.117382
32. Xie, Z., and Miller, G. M. (2009). A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain. J. Pharmacol. Exp. Ther. 330, 316-325. doi: 10.1124/jpet.109.153775
33. Xie, Z., Westmoreland, S. V., Bahn, M. E., Chen, G. L., Yang, H., Vallender, E. J., et al. (2007). Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J. Pharmacol. Exp. Ther. 321, 116-127. doi: 10.1124/jpet.106.116863
34. Xie, Z., Westmoreland, S. V., and Miller, G. M. (2008). Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes. J. Pharmacol. Exp. Ther. 325, 629-640. doi: 10.1124/jpet.107.135079
35. Yamada, S., Kojima, H., Yokoo, H., Tsutsumi, T., Takamuki, K., Anraku, S., et al. (1988). Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine. Biol. Psychiatry 24, 399-408. doi: 10.1016/0006-3223(88)90176-X